Patterns of decline in upper limb function of boys and men with DMD: an international survey

With increasing life expectancy, upper extremity (UE) function becomes more and more important in boys with Duchenne muscular dystrophy (DMD). Knowledge of UE function in these children is, however, limited. The aim of this study was to gain insight into the changing patterns of UE function during the course of DMD. A Web-based questionnaire on UE function, covering all domains of the International Classification of Functioning Disability and Health, was distributed worldwide. Primary domains of the questionnaire were: participant characteristics, UE pain and stiffness, UE activities, and social participation. Data were described per disease stage and analyzed using descriptive analysis. A total of 213 boys/men with DMD (1–35 years) were included in this study. UE pain, stiffness, and activity limitations increased with disease stage. UE activity limitations already occurred in the early ambulatory stage. Compared to the healthy population, social participation was restricted in DMD patients and about 70 % of the respondents experienced UE limitations when performing social activities. Despite the existence of UE impairments, only 9 % of the respondents used supportive aids. Functional capacities and activities of the UE are limited already in the early ambulatory stage of patients with DMD affecting their social participation. Therefore, clinicians should pay attention to UE limitations before DMD patients lose their capacity to walk. Effective and adequate aids as well as attention for pain and stiffness in the therapeutic management could help to reduce UE activity limitations and related restrictions in social participation.

[1]  K. Bloch,et al.  Disability and survival in Duchenne muscular dystrophy , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[2]  G. Chard International Classification of Functioning, Disability and Health , 2004 .

[3]  Charlotte M Druschel,et al.  Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). , 2009, The Journal of pediatrics.

[4]  Sang Joon Kim,et al.  The Correlation Analysis of Functional Factors and Age with Duchenne Muscular Dystrophy , 2012, Annals of rehabilitation medicine.

[5]  W M Fowler,et al.  Upper extremity functional rating for patients with Duchenne muscular dystrophy. , 1987, Archives of physical medicine and rehabilitation.

[6]  J A Shea,et al.  The Capabilities of Upper Extremity instrument: reliability and validity of a measure of functional limitation in tetraplegia. , 1998, Archives of physical medicine and rehabilitation.

[7]  John Bourke,et al.  Managing Duchenne muscular dystrophy – The additive effect of spinal surgery and home nocturnal ventilation in improving survival , 2007, Neuromuscular Disorders.

[8]  B. Katirji Diagnostic Criteria for Neuromuscular Disorders , 1994, Neurology.

[9]  A. Thevenon,et al.  Pain and Neuromuscular Disease: The Results of a Survey , 2006, American journal of physical medicine & rehabilitation.

[10]  N. van Alfen,et al.  Health-Related Quality of Life and Its Relation to Disease Severity in Boys With Duchenne Muscular Dystrophy , 2014, Journal of child neurology.

[11]  R. Barro,et al.  International Data on Educational Attainment Updates and Implications , 2000 .

[12]  J. Thonnard,et al.  Validation of the ABILHAND questionnaire to measure manual ability in children and adults with neuromuscular disorders , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[13]  D. Drotar,et al.  Pain and activity limitations in children with Duchenne or Becker muscular dystrophy , 2008, Developmental medicine and child neurology.

[14]  Vicente Gilsanz,et al.  Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. , 2008, AJR. American journal of roentgenology.

[15]  T. Rahman,et al.  A body-powered functional upper limb orthosis. , 2000, Journal of rehabilitation research and development.

[16]  R. Abresch,et al.  Profiles of neuromuscular diseases. Becker's muscular dystrophy. , 1995, American journal of physical medicine & rehabilitation.

[17]  M. Jensen,et al.  Pain in Youths With Neuromuscular Disease , 2009, The American journal of hospice & palliative care.

[18]  Krista Vandenborne,et al.  Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy. , 2012, Physical medicine and rehabilitation clinics of North America.

[19]  M. Brooke,et al.  Clinical trial in duchenne dystrophy. I. The design of the protocol , 1981, Muscle & nerve.

[20]  R. Finkel,et al.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management , 2010, The Lancet Neurology.

[21]  G. V. Ommen,et al.  Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD) , 2011, Neuromuscular Disorders.

[22]  Arnaud Desurmont,et al.  Youth in Europe - A statistical portrait , 2009 .

[23]  Krista Vandenborne,et al.  Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health , 2012, Health and Quality of Life Outcomes.

[24]  B. Mastenbroek,et al.  Development of a Mobile Arm Support (Armon): Design Evolution and Preliminary User Experience , 2007, 2007 IEEE 10th International Conference on Rehabilitation Robotics.

[25]  F Goubel,et al.  Muscle and joint elastic properties during elbow flexion in Duchenne muscular dystrophy , 2001, The Journal of physiology.

[26]  G. Ahlström,et al.  Activities of daily living and quality of life in persons with muscular dystrophy. , 2001, Journal of rehabilitation medicine.

[27]  S. Pandya,et al.  Use of Corticosteroids in a Population-Based Cohort of Boys With Duchenne and Becker Muscular Dystrophy , 2010, Journal of child neurology.

[28]  M. Grootenhuis,et al.  Living with muscular dystrophy: health related quality of life consequences for children and adults , 2007, Health and quality of life outcomes.

[29]  Cindy Hamil,et al.  Evidence‐based path to newborn screening for duchenne muscular dystrophy , 2012, Annals of neurology.

[30]  T. Armstrong,et al.  Test-retest reliability of the Upper Extremity Questionnaire among keyboard operators. , 2001, American journal of industrial medicine.